Mesirow Financial Investment Management - Fixed Income’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,335	Closed	-$248K	–	107
2022 Q2	$248K	Buy	3,335 +95	+3%	+$7.13K	0.03%	118
2022 Q1	$291K	Buy	+3,240	New	+$299K	0.03%	117

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's XBI Position: Q3 2022 in Review

Mesirow Financial Investment Management - Fixed Income sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 3,335 shares — an estimated $248K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in XBI in Q1 2022 and held it in 2 quarters. The position peaked at $291K in Q1 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Mesirow Financial Investment Management - Fixed Income reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 3,335 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $248K.
Mesirow Financial Investment Management - Fixed Income first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 2 quarters.
Mesirow Financial Investment Management - Fixed Income's State Street SPDR S&P Biotech ETF position peaked at $291K in Q1 2022.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q3 2022, filed 8 Nov 2022.